Partial Manifestation of Anti-NMDA-R Encephalitis with Predominant Movement Disorder

Movement Disorders Clinical Practice

Volumn 3, Issue 1, 2016, Pages 80-82

  Udani, Vrajesh ^a   Desai, Neelu ^a   Botre, Abhijeet ^a  

^a P D HINDUJA NATIONAL HOSPITAL   (India)

Author keywords

Ataxia; Chorea; Movement disorder; Oligosymptomatic; Partial anti NMDA R encephalitis

Indexed keywords

ETIRACETAM; IMMUNOGLOBULIN; MEPREDNISONE; PREDNISOLONE;

ANTI N METHYL D ASPARTATE RECEPTOR ENCEPHALITIS; ANXIETY; ARTICLE; BEHAVIOR CHANGE; CASE REPORT; CHILD; ECHOGRAPHY; ELECTROENCEPHALOGRAPHY; HUMAN; MALE; MOTOR DYSFUNCTION; NUCLEAR MAGNETIC RESONANCE IMAGING; PRESCHOOL CHILD; PRIORITY JOURNAL; SCHOOL CHILD; SEIZURE; SLEEP DISORDER;

EID: 84976893835     PISSN: None     EISSN: 23301619     Source Type: Journal    
DOI: 10.1002/mdc3.12221     Document Type: Article

References (9)

1. Dalmau J, Tuzun E, Wu HY, et al. Paraneoplastic anti-N-methyl-d-aspartate receptor encephalitis associated with ovarian teratoma. Ann Neurol 2007;61:25-36.
2. Gable MS, Sheriff H, Dalmau J, Tilley DH, Glaser CA. The frequency of autoimmune N-methyl-d-aspartate receptor encephalitis surpasses that of individual viral etiologies in young individuals enrolled in the California Encephalitis Project. Clin Infect Dis 2012;54:899-904.
3. Dale RC, Singh H, Troedson C, Pillai S, Gaikiwari S, Kozlowska K. A prospective study of acute movement disorders in children. Dev Med Child Neurol 2010;52:739-748.
4. Dale RC, Merheb V, Pillai S, et al. Antibodies to surface dopamine-2 receptor in autoimmune movement and psychiatric disorders. Brain 2012;135:3453-3468.
5. Hacohen Y, Dlamini N, Hedderly T, et al. N-methyl-d-aspartate receptor antibody-associated movement disorder without encephalopathy. Dev Med Child Neurol 2014;56:190-193.
6. Armangue T, Titulaer MJ, Málaga I, et al. Pediatric anti-N-methyl-d-aspartate receptor encephalitis-clinical analysis and novel findings in a series of 20 patients. J Pediatr 2013;162:850-856.
7. Titulaer MJ, McCracken L, Gabilondo I, et al. Treatment and prognostic factors for long-term outcome in patients with anti-NMDA receptor encephalitis: an observational cohort study. Lancet Neurol 2013;12:157-165.
8. Rubio-Agustí I, Dalmau J, Sevilla T, Burgal M, Beltrán E, Bataller L. Isolated hemidystonia associated with NMDA receptor antibodies. Mov Disord 2011;26:351-352.
9. Kayser MS, Titulaer MJ, Gresa-Arribas N, Dalmau J. Frequency and characteristics of isolated psychiatric episodes in anti-N-methyl-d-aspartate receptor encephalitis. JAMA Neurol 2013;70:1133-1139.